AIM ImmunoTech Inc. (AIM) Financials
AIM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-10-31 | 27.9 million | 5.3 million |
| 2023-07-31 | 33.6 million | 3.5 million |
| 2023-04-30 | 37.5 million | 2.5 million |
| 2023-01-31 | 40.5 million | 2.0 million |
AIM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-10-31 | -5.9 million | 50000 |
| 2023-07-31 | -2.4 million | 50000 |
| 2023-04-30 | -3.7 million | 82000 |
| 2023-01-31 | -6.2 million | 162000 |
AIM Net Income
No data available :(
AIM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-10-31 | 22.4 million | - | - |
| 2023-07-31 | 28.4 million | - | 750000 |
| 2023-04-30 | 30.8 million | - | 803000 |
| 2023-01-31 | 34.2 million | - | 814000 |
AIM Shares Outstanding
AIM Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-10-31 | 184000 | 2.7 million | 5.4 million | - |
| 2023-07-31 | 203000 | 3.0 million | 2.6 million | - |
| 2023-04-30 | 29000 | 2.1 million | 2.3 million | - |
| 2023-01-31 | 175000 | 2.1 million | 3.5 million | - |
AIM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-10-31 | 46000 | 30000 |
| 2023-07-31 | 42000 | 91000 |
| 2023-04-30 | 49000 | 84000 |
| 2023-01-31 | 56000 | 19.8 million |
AIM
Price: $0.43
52 week price:
Earnings Per Share: -0.43 USD
P/E Ratio: -0.91
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 36383
Market Capitalization: 23.3 million